CUMMINGS KEITH LAMONT (Chief Financial Officer) received a stock award from PLIANT THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/11/2024ACC: 0001746473-24-000115
Officer· Chief Financial Officer
Since Jun 2020
+21.31K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
21.31K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+21.31K
Price / share
—
Trade value
—
% of position
7.8%
7/9/2024
271.71K→293.03K
Total
Net shares
+21.31K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/9/2024 | A · Award | +21.31K | — | — | 7.8% | 271.71K | 293.03K |
| Total | +21.31K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported